A Randomized, Placebo-Controlled Trial to Evaluate the Effects of Phenylephrine HCl 30 mg Extended-Release Tablets on Nasal Congestion in Subjects With Allergic Rhinitis.

Trial Profile

A Randomized, Placebo-Controlled Trial to Evaluate the Effects of Phenylephrine HCl 30 mg Extended-Release Tablets on Nasal Congestion in Subjects With Allergic Rhinitis.

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Nov 2015

At a glance

  • Drugs Phenylephrine (Primary)
  • Indications Seasonal allergic rhinitis
  • Focus Registrational; Therapeutic Use
  • Sponsors Bayer
  • Most Recent Events

    • 07 Nov 2015 Primary endpoint (Mean Change From Baseline in Daily Reflective Nasal Congestion Score) has not been met as per the results published in the Annals of Allergy, Asthma and Immunology.
    • 07 Nov 2015 Results published in the Annals of Allergy, Asthma and Immunology
    • 28 Jan 2013 Lead trial centre amended as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top